Ainos, Inc. Stock

AIMD

US00902F4028

Advanced Medical Equipment & Technology

Market Closed - Nasdaq Other stock markets 00:00:00 06/08/2026 +04			5-day change	1st Jan Change
1.420 ^USD	+0.71%		+7.58%	-13.41%

08-04	Ainos, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
05-27	Top Premarket Decliners	MT

Ainos, Inc. is a dual-platform AI and biotech company advancing SmellTech and immune therapeutics. Its AI Nose platform and smell language model (SML) digitize scent into Smell ID, a machine-readable data, powering applications across robotics, smart factories, and healthcare. It is also developing VELDONA, an oral low-dose interferon therapy targeting rare diseases, autoimmune diseases, infectious diseases, and animal health. Its pipeline includes drug candidates for treating oral warts for human immunodeficiency virus seropositive patients, Sjogrenâ€™s syndrome, and feline chronic gingivostomatitis, a cat oral infection. Its product pipeline includes VELDONA Pet, VELDONA human drugs, AI Nose - NISD co-development, AI Nose industrial and robotics application, VOC POCT, VOC POCT Ainos Pen, VOC POCT CHS430, and Synthetic RNA (SRNA). VOC POCT-Ainos Pen is a device intended to be a cloud-connected, multipurpose, portable breath analyzer that is intended to monitor health conditions.

Employees

Sector

Advanced Medical Equipment & Technology

More about the company

Quotes

Date	Price	Change	Volume
05/08/26	$1.420	+0.71%	22,338
04/08/26	$1.410	-2.76%	199,683
03/08/26	$1.450	+9.02%	3,424,271
31/07/26	$1.330	-2.21%	19,350
30/07/26	$1.360	+3.03%	17,661

Delayed Quote Nasdaq

More quotes

Income Statement and Estimates

More financial data

Market Cap	10.46M 9.06M 8.44M 7.77M 14.66M 994M 14.82M 99.22M 38.94M 498M 39.28M 38.41M 1.65B	P/E 2024	-0.29x	P/E 2025	-0.47x
Enterprise Value	21.04M 18.22M 16.99M 15.62M 29.5M 2B 29.82M 200M 78.35M 1B 79.02M 77.28M 3.32B	EV / Sales 2024	701x	EV / Sales 2025	162x
Free-Float	33.75%	Yield 2024 *	-	Yield 2025	-

08-04	Ainos, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
05-27	Top Premarket Decliners	MT
05-14	Ainos, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
03-31	Ainos, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025	CI
03-30	Ainos, Inc. Auditor Raises 'Going Concern' Doubt	CI
01-06	Ainos on Dec 30 2025, enters distribution agreement with Trusval Technology	RE
01-06	Ainos, Inc. Enters into a Distribution Agreement with Trusval Technology Co. Ltd	CI
11-14	Ainos, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI
14/08/25	Ainos, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025	CI
07/08/25	Ainos, Inc. Secures $2.1 Million Order with ASE Technology Holding Co., Ltd	CI
27/06/25	Ainos, ASE Technology to Expand AI Nose Technology in Semiconductor Facility	MT
26/06/25	Ainos Plans 1-for-5 Reverse Stock Split	MT
24/06/25	Ainos, Inc. and Kenmec Mechanical Engineering Co., Ltd. Launch Strategic Partnership to Deploy Ai-Powered Scent Intelligence in Smart Factories Across Asia	CI

08-04	Ainos Reports Second Quarter 2026 Results and Highlights Continued AI Nose Execution Across Industrial, Healthcare Infrastructure and Robotics Markets	AQ
07-21	Ainos Expands Smell AI With Growing Real-World Scent Dataset for Physical AI	AQ
06-22	VASRO Research Highlights Ainos' Expansion of Smell AI Into Patient-Level Breath Intelligence	AQ
06-17	RedChip's Future Tech Investor Conference Replays Now Available	AQ
06-17	Ainos Expands Smell AI Platform into Digital Breath Intelligence Through National Taiwan University Research Program	AQ

1 day	+0.71%
1 week	+7.58%
Current month	+6.77%
1 month	-24.06%
3 months	-17.92%
6 months	-27.18%
Current year	-13.41%

1 week	1.31	1.53
1 month	1.3	2.03
Current year	1.26	3.88
1 year	1.26	4.44
3 years	1.26	23.72
5 years	1.26	450
10 years	1.26	1,781.25

Ainos, Inc. Stock

Stocks

AIMD

US00902F4028

Advanced Medical Equipment & Technology

Valuation: Ainos, Inc.

Chart: Ainos, Inc.

Latest news : Ainos, Inc.

Press Releases: Ainos, Inc.

Quotes and Performance

Course Extremes

Managers and Directors: Ainos, Inc.

Latest insider transactions

Other Advanced Medical Equipment & Technology

Financials

Company Profile

Quotes

Income Statement and Estimates

Manager	Title	Age	Since
Chun Hsien Tsai CEO	Chief Executive Officer	56	15/04/2021
Christopher Lee DFI	Director of Finance/CFO	54	15/03/2024

Director	Title	Age	Since
Chung Yi Tsai BRD	Director/Board Member	49	15/04/2021
Chung Jung Tsai BRD	Director/Board Member	54	15/04/2021
Ting Chuan Lee BRD	Director/Board Member	42	15/04/2021

Date	Insider	Type	Main position	Quantity	% Market Cap.
19/05/26	Yao Chung Chiang	Buy	Director	2,200	0.0315%
29/04/26	Yao Chung Chiang	Buy	Director	300	0.0041%
28/01/26	Taiwan Carbon Nano Technology Corp.	Sell	Company	46,000	0.6588%

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
AINOS, INC.	+0.71%	+7.58%	-39.06%	-93.69%	10.46M
THERMO FISHER SCIENTIFIC, INC.	+2.32%	+0.24%	+23.89%	+5.32%	214B
DANAHER CORPORATION	+2.51%	+1.61%	+0.31%	-21.63%	140B
INTUITIVE SURGICAL, INC.	+1.88%	+6.26%	-21.34%	+21.30%	133B
BOSTON SCIENTIFIC CORPORATION	-2.75%	+3.69%	-54.46%	-5.88%	69.19B
EDWARDS LIFESCIENCES CORPORATION	-0.70%	+3.74%	+12.28%	+11.84%	51.28B
SIEMENS HEALTHINEERS AG	+0.62%	+4.53%	-14.27%	-20.39%	50.43B
AGILENT TECHNOLOGIES, INC.	+1.37%	+0.58%	+22.82%	+11.73%	39.85B
WATERS CORPORATION	+0.99%	+5.41%	+42.25%	+37.98%	39.27B
RESMED, INC.	+0.40%	+4.55%	-21.39%	+24.98%	32.32B
Average	+0.52%	+4.15%	-4.90%	-2.84%	76.89B
Weighted average by Cap.	+0.95%	+3.04%	+0.44%	+3.72%

	2024	2025
Net sales	20.73K 17.95K 16.74K 15.39K 29.06K 1.97M 29.38K 197K 77.19K 986K 77.85K 76.14K 3.27M	124K 108K 100K 92.19K 174K 11.81M 176K 1.18M 462K 5.91M 466K 456K 19.56M
Net income	-14.86M -12.87M -12M -11.04M -20.84M -1.41B -21.07M -141M -55.35M -707M -55.82M -54.59M -2.34B	-14.77M -12.79M -11.93M -10.97M -20.71M -1.4B -20.94M -140M -55M -703M -55.48M -54.25M -2.33B
Net Debt	8.11M 7.02M 6.55M 6.02M 11.36M 771M 11.49M 76.92M 30.19M 386M 30.45M 29.78M 1.28B	10.58M 9.17M 8.54M 7.86M 14.84M 1.01B 15M 100M 39.41M 503M 39.75M 38.87M 1.67B